• Clear Filters

138 Results |

Respiratory Syncytial Virus (RSV) Prevention study group, Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

Publication date: 10/23/2015

Authors: O'Brien KL, Chandran A, Weatherholtz R, Jafri HS, Griffin MP, Bellamy T, Millar EV, Jensen KM, Harris BS, Reid R, Moulton LH, Losonsky GA, Karron RA, Santosham M

Publication: Lancet Infect Disease

Focus Area: Infectious Disease Prevention